IMUX Immunic Inc: Accounting Value per Share
Immunic, Inc. (IMUX) reputation for developing oral immunomodulators for the treatment of psoriasis confirms the temporal trajectory on the GURU.Markets chart, where the current bvps value has reached 9.37. A lack of profitability and reliance on investment due to R&D expenses limit margins while the company progresses through clinical trial stages, which directly impacts net asset dynamics.
Immunic Therapeutics - analytical breakdowns and key metrics (IMUX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:immunic-therapeutics.com - IMUX
Defensive assets are selected based on their ability to preserve net capital value, which is critical for Immunic, Inc. (IMUX), as the company minimizes costs through automated bioinformatic molecule design. By analyzing the book value per share trend, an investor assesses the residual value of the business net of liabilities, determining the real tangible value of each ownership stake within the company's fundamental value.
Competitors of Immunic, Inc. (IMUX)
Argenx - Accounting Value per Share|BioNTech Pharma (BNTX) - Book Value per Share|Accounting Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Book Value per Share ATXS (Astria Pharma)|ENGN: Net Assets per Share|RAPT (RAPT Therapeutics, Inc.) - Net Assets per Single Share|JBIO (Aerovate Therapeutics) - Accounting Value per Share|Net Assets per Single Share ACRS|Accounting Value per Share Kyverna Therapeutics Inc. (KYTX)|Accounting Value per Share TLSA|Book Value per Share CABA (Cabaletta Bio Inc)|VTYX - Net Assets per Single Share|Equity per Share theratech.com THTX|Book Value per Share AVTX (Avalo Therapeutics)|ELDN - Net Assets per Share|AGEN (Agenus Inc) - Book Value per Share|Accounting Value per Share Climb Bio, Inc|ZURA - Accounting Value per Share|Accounting Value of a Share atyrpharma.com|ADAG (Adagene) - Book Value per Share|Net Assets per Share IMA (ikenaoncology.com)|STTK - Net Assets per Single Share|Equity per Share Equillium Inc EQ|CNTB: Book Value per Share|Atara Biotherapeutics (ATRA) - Accounting Value per Share|inflarx.de - Accounting Value per Share|X4 Pharmaceuticals Inc. (XFOR) - Net Assets per Share|ACET: Book Value per Share|Net Assets per Share CELU|Net Assets per Single Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Book Value per Share|Akari Therapeutics plc (AKTX) - Accounting Value per Share|ENLV: Equity per Share|Net Assets per Single Share q32bio.com (QTTB)|geovax.com (GOVX) - Share Book Value|EDSA - Book Value per Share|Accounting Value of a Share iBio Inc|Book Value per Share CARM|Book Value per Share XTLB (XTL Bio)|Net Assets per Single Share Bolt Biotherapeutics, Inc.|HCW Biologics, Inc. - Accounting Value of a Share|APVO: Net Assets per Single Share|AIM - Accounting Value per Share|ADTX: Book Value per Share|Book Value per Share GRI Bio Corporation|XRTX - Accounting Value per Share|Accounting Value of a Share reshapelifesciences.com|REVB (Revelation Biosciences, Inc.) - Book Value per Share|Net Assets per Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|CalciMedica Inc - Accounting Value per Share|AFMD: Net Assets per Single Share|Allakos Inc. (ALLK) - Accounting Value per Share|HOOK: Accounting Value per Share|IGMS (IGM Biosciences) - Book Value per Share|Net Assets per Single Share iTeos (ITOS)|Equity per Share Ocean Biomedical Corp|TC Biopharm - Book Value per Share|Net Asset Value per Share thirdharmonicbio.com (THRD)